Literature DB >> 1692847

Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease.

K Yoshioka1, S Kakumu, M Arao, Y Tsutsumi, M Inoue, T Wakita, T Ishikawa, M Mizokami.   

Abstract

To determine the intrahepatic production of tumour necrosis factor alpha (TNF alpha) in chronic liver disease three monoclonal antibodies were used against TNF alpha in immunohistochemical studies of liver tissue sections from patients with chronic liver disease. All three monoclonal antibodies stained infiltrating mononuclear cells. Monoclonal antibody II 7C2 also stained the cytoplasm or nucleus, or both, of a varied number of hepatocytes from nine patients with chronic hepatitis B virus infection, suggesting that the antigenic epitope related to hepatitis B core antigen (HBcAg) crossreacted with II7C2. The other two monoclonal antibodies, III2F3 and IV3E5, stained significantly larger numbers of mononuclear cells in cases of chronic active hepatitis B than in chronic persistent hepatitis B, or hepatitis B related liver cirrhosis. III2F3 stained significantly larger numbers of mononuclear cells in non-A, non-B chronic active hepatitis than in chronic persistent hepatitis B or hepatitis B related liver cirrhosis. These results indicate that TNF alpha is produced and secreted by infiltrating mononuclear cells in focal inflammatory areas of the liver, and suggest that TNF alpha may have a role in the inflammatory activity of chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692847      PMCID: PMC502358          DOI: 10.1136/jcp.43.4.298

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

2.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.

Authors:  S C Wright; B Bonavida
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

4.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

5.  Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases.

Authors:  Y Kato; H Nakagawa; K Kobayashi; N Hattori; K Hatano
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

6.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

7.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

8.  Immunochemical structure of hepatitis B e antigen in the serum.

Authors:  K Takahashi; A Machida; G Funatsu; M Nomura; S Usuda; S Aoyagi; K Tachibana; H Miyamoto; M Imai; T Nakamura; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha.

Authors:  S Yokota; T D Geppert; P E Lipsky
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

10.  Spontaneous production of tumor necrosis factor alpha by Kupffer cells of MRL/lpr mice.

Authors:  D B Magilavy; J L Rothstein
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  8 in total

1.  Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease.

Authors:  S Kakumu; A Fukatsu; T Shinagawa; S Kurokawa; A Kusakabe
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  Apoptosis induced by tumor necrosis factor-alpha in rat hepatocyte cell lines expressing hepatitis B virus.

Authors:  S Guilhot; T Miller; G Cornman; H C Isom
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

3.  Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon.

Authors:  Y Itoh; T Okanoue; S Sakamoto; K Nishioji; K Yasui; M Sakamoto; K Kashima
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

4.  Falsely Elevated Serum Vitamin B12 Levels Were Associated with the Severity and Prognosis of Chronic Viral Liver Disease.

Authors:  Takaaki Sugihara; Masahiko Koda; Toshiaki Okamoto; Kenichi Miyoshi; Tomomitsu Matono; Kenji Oyama; Keiko Hosho; Jun-Ichi Okano; Hajime Isomoto; Yoshikazu Murawaki
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

5.  Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.

Authors:  M J Hussain; J Y Lau; R Williams; D Vergani
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

6.  Increased tumour necrosis factor alpha production by neutrophils in patients with hepatitis B.

Authors:  X Fan; Z Zhang
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

Review 7.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.

Authors:  L H Calabrese; N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 8.  Modulation of signaling pathways by RNA virus capsid proteins.

Authors:  Matthew D Urbanowski; Carolina S Ilkow; Tom C Hobman
Journal:  Cell Signal       Date:  2008-01-04       Impact factor: 4.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.